Literature DB >> 6299946

Structure and biological properties of solubilized envelope proteins of Bordetella pertussis.

A Robinson, D C Hawkins.   

Abstract

The structure and biological properties of solubilized envelope proteins of Bordetella pertussis have been examined. Several envelope proteins were found to be specific for phase I strains of B. pertussis and could be isolated by selective detergent extraction. These proteins had molecular weights of 90,000, 86,000, 81,000, 33,000, 31,000, and 30,000 and were reduced or absent in envelope preparations from Bordetella bronchiseptica, Bordetella parapertussis, or phase IV strains of B. pertussis. When the envelope preparations from phase I B. pertussis were assayed in the mouse intracerebral protection test they were found to be highly protective, and there was a strong correlation between the protective potency and the lymphocytosis-promoting factor (LPF) content of different preparations. Treatment with glutaraldehyde reduced the LPF activity, toxicity, and protective potency of the envelope extracts. Similarly affinity chromatography of envelope proteins on columns of haptoglobin coupled to Sepharose 4B reduced both the LPF content and the protective potency. The addition of a small amount of purified LPF to the haptoglobin-treated proteins restored the protective potency. The LPF by itself was nonprotective, indicating a potentiating role of LPF in the mouse intracerebral challenge test.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6299946      PMCID: PMC347993          DOI: 10.1128/iai.39.2.590-598.1983

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  20 in total

1.  Mouse Protection Tests in the Study of Pertussis Vaccine: A Comparative Series Using the Intracerebral Route for Challenge.

Authors:  P L Kendrick; G Eldering; M K Dixon; J Misner
Journal:  Am J Public Health Nations Health       Date:  1947-07

2.  Electrophoretic analysis of the major polypeptides of the human erythrocyte membrane.

Authors:  G Fairbanks; T L Steck; D F Wallach
Journal:  Biochemistry       Date:  1971-06-22       Impact factor: 3.162

3.  Phase-shift markers in Bordetella: alterations in envelope proteins.

Authors:  J W Ezzell; W J Dobrogosz; W E Kloos; C R Manclark
Journal:  J Infect Dis       Date:  1981-04       Impact factor: 5.226

4.  Solubilization of the cytoplasmic membrane of Escherichia coli by the ionic detergent sodium-lauryl sarcosinate.

Authors:  C Filip; G Fletcher; J L Wulff; C F Earhart
Journal:  J Bacteriol       Date:  1973-09       Impact factor: 3.490

5.  Subtyping isolates of Haemophilus influenzae type b by outer-membrane protein profiles.

Authors:  S J Barenkamp; R S Munson; D M Granoff
Journal:  J Infect Dis       Date:  1981-05       Impact factor: 5.226

6.  Rabbit nasopharyngeal colonization by Bordetella pertussis: the effects of immunization on clearance and on serum and nasal antibody levels.

Authors:  L A Ashworth; R B Fitzgeorge; L I Irons; C P Morgan; A Robinson
Journal:  J Hyg (Lond)       Date:  1982-06

7.  Chemical analysis of major outer membrane proteins of Neisseria meningitidis: comparison of serotypes 2 and 11.

Authors:  C M Tsai; C E Frasch
Journal:  J Bacteriol       Date:  1980-01       Impact factor: 3.490

8.  Leukocytosis-promoting factor of Bordetella pertussis. 3. Its identity with protective antigen.

Authors:  Y Sato; H Arai; K Suzuki
Journal:  Infect Immun       Date:  1974-05       Impact factor: 3.441

9.  Mouse-protecting and histamine-sensitizing activities of pertussigen and fimbrial hemagglutinin from Bordetella pertussis.

Authors:  J J Munoz; H Arai; R L Cole
Journal:  Infect Immun       Date:  1981-04       Impact factor: 3.441

10.  Isolation and properties of the leukocytosis- and lymphocytosis-promoting factor of Bordetella pertussis.

Authors:  S I Morse; J H Morse
Journal:  J Exp Med       Date:  1976-06-01       Impact factor: 14.307

View more
  13 in total

1.  Bordetella pertussis major outer membrane porin protein forms small, anion-selective channels in lipid bilayer membranes.

Authors:  S K Armstrong; T R Parr; C D Parker; R E Hancock
Journal:  J Bacteriol       Date:  1986-04       Impact factor: 3.490

2.  Identification of a 68-kilodalton protective protein antigen from Bordetella bronchiseptica.

Authors:  J A Montaraz; P Novotny; J Ivanyi
Journal:  Infect Immun       Date:  1985-03       Impact factor: 3.441

3.  Cloning of Bordetella pertussis outer membrane proteins in Escherichia coli.

Authors:  F Shareck; J Cameron
Journal:  J Bacteriol       Date:  1984-08       Impact factor: 3.490

4.  Surface proteins of Bordetella pertussis: comparison of virulent and avirulent strains and effects of phenotypic modulation.

Authors:  S K Armstrong; C D Parker
Journal:  Infect Immun       Date:  1986-11       Impact factor: 3.441

5.  Heat-modifiable envelope proteins of Bordetella pertussis.

Authors:  S K Armstrong; C D Parker
Journal:  Infect Immun       Date:  1986-10       Impact factor: 3.441

6.  Isolation of the outer membrane components of Bordetella pertussis which enhance the immunogenicity of Haemophilus influenzae type b capsular polysaccharide polyribosyl ribitol phosphate.

Authors:  N Monji; M R Stebbins; D W McCoy; J S Kuo
Journal:  Infect Immun       Date:  1986-03       Impact factor: 3.441

7.  Adenylate cyclase activity of a 68,000-molecular-weight protein isolated from the outer membrane of Bordetella bronchiseptica.

Authors:  P Novotny; A P Chubb; K Cownley; J A Montaraz
Journal:  Infect Immun       Date:  1985-10       Impact factor: 3.441

8.  Characterization of the outer membrane proteins of Bordetella avium.

Authors:  R Leyh; R W Griffith
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

9.  Serum antibody responses to the outer membrane proteins of Bordetella pertussis.

Authors:  K Redhead
Journal:  Infect Immun       Date:  1984-06       Impact factor: 3.441

10.  Isolation and characterization of Bordetella avium phase variants.

Authors:  C R Gentry-Weeks; D L Provence; J M Keith; R Curtiss
Journal:  Infect Immun       Date:  1991-11       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.